Unbiased
The best option for you — not simply sending you to the same lab.
Why Nome
Faster. Cheaper. Transparent.
The only platform built to take rare disease patients from diagnosis to treatment — faster, cheaper, and with full transparency.
The Nome Difference
What sets us apart.
Scientifically rigorous
Industry-experienced PhDs who know how to develop therapies that reach patients.
Control
You control what you fund and own what you develop.
Urgency
We move at patient-driven speed.
Timeline Compression
From years to weeks.
Without Nome
2.5–3+ years before experiments begin — searching, networking, meetings with wrong-fit organizations, then months of contracting and onboarding.
With Nome
~60 days to experiments underway with world-class partners — AI strategy, development plan, competitive RFP, vendor selection, SOW execution, and program launch.
95% time compression from search to contracted development.
Hybrid Network
Commercial research services and academic labs, side by side.
Nome is the only platform with established access to both leading commercial research services and top academic research laboratories. This hybrid network means families are never limited to one institution's technology or one company's capabilities.
Every program goes through a structured, competitive RFP. Multiple qualified vendors are evaluated side-by-side on scientific capability, capacity, pricing, and timeline. Families see the full competitive picture with complete transparency.
Ready to see what's possible?